Skip to main navigation Skip to search Skip to main content

Maximal secretory capacity of somatotrope cells in obesity: Comparison with GH deficiency

  • M. Maccario
  • , M. R. Valetto
  • , P. Savio
  • , G. Aimaretti
  • , C. Baffoni
  • , M. Procopio
  • , S. Grottoli
  • , S. E. Oleandri
  • , E. Arvat
  • , E. Ghigo

Research output: Contribution to journalArticlepeer-review

Abstract

OBJECTIVE: To evaluate the maximal secretory capacity of somatotrope cells in obesity and to compare it with that in hypopituitaric patients with GH deficiency. DESIGN: Stimulation with GHRH. (1 μg/kg iv) combined with arginine (ARG, 0.5 g/kg iv), which strongly potentiates the GH response to the neurohormone, likely inhibiting hypothalamic somatostatin. The reproducibility of the GH response to GHRH + ARG was evaluated in a second session. SUBJECTS: Forty-five patients with simple obesity (OB 11 male and 34 female, age 40.5 ± 1.8 y, BMI 38.8 ± 1.1 kg/m2), 49 patients with hypopituitarism (GHD, 23 male and 26 female, 43.6 ± 2.4y, 24.7 ± 0.7 kg/m2) and 44 normal young volunteers INS, 25 male and 19 female, 33.8 ± 1.0 y, 21.6 ± 0.3 kg/m2) were studied. MEASUREMENTS: GH levels were assayed by IRMA method, basally at - 60 and 0 min, and than every 15 min up to + 120 min. Basal IGF-I levels were assayed by RIA method, after acid-ethanol extraction. RESULTS: IGF-I levels in OB were lower (Pi 0.005) than those in NS but higher (P < 0.005) than those in GHD. Mean peak GH response to GUSH ± ARG in OB was clearly lower than that in NS (P < 0.005) and higher (P < 0.005) than that in GHD. Sixty-percent OB and 100% GHD showed peak GH responses lower than the minimum normal limit in NS (16.5 μg/l) while 4% OB and only 53% GHD with GH responses lower than 3 μg/l, the limit under which GH replacement therapy of severe deficiency is allowed. Good intraindividual reproducibility of the GH response to GHRH + arginine test was present in all groups (OB: r=0.78, P < 0.0001; GHD: r= 0.57, P < 0.003; NS: r= 0.74, P < 0.0001;. CONCLUSIONS: The maximal secretory capacity of somatotrope cells is clearly less than normal in the obese but still more than is seen in GHD subjects. However, in about 50% of obese patients, the pituitary GH releasable pool overlaps with that of hypopituitaric patients with GH deficiency. Thus, even when the maximal secretory capacity of somatotrope cells is evaluated by a potent and reproducible provocative tests such as GHRH + arginine, overweight has to be taken in a great account as the cause of severely impaired GH response in patients with suspected GH deficiency.

Original languageEnglish
Pages (from-to)27-32
Number of pages6
JournalInternational Journal of Obesity
Volume21
Issue number1
DOIs
Publication statusPublished - 1997
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • GH
  • GH deficiency
  • GHRH + arginine
  • Obesity

Fingerprint

Dive into the research topics of 'Maximal secretory capacity of somatotrope cells in obesity: Comparison with GH deficiency'. Together they form a unique fingerprint.

Cite this